Back to Search
ROBERT BOCIEK, MD
MD
Hematology & Oncology Physician
NPI: 1942268768IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
20918(NE)
Education
OTHER
Class of 1988
Research & Publications (20)
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
PMID 19055670·Br J Haematol·2009
3-trial
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
PMID 17932394·Ann Oncol·2008
8-other
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.
PMID 18079362·Blood·2008
3-trial
Adult Burkitt lymphoma: advances in diagnosis and treatment.
PMID 19133605·Oncology (Williston Park)·2008
6-review
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
PMID 18662967·J Clin Oncol·2008
8-other
Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
PMID 19074837·Mol Cancer Res·2008
8-other
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
PMID 17296974·J Clin Oncol·2007
3-trial
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.
PMID 18065735·J Clin Oncol·2007
8-other
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
PMID 17875758·Clin Cancer Res·2007
8-other
Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
PMID 17786276·Int J Mol Med·2007
8-other
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.
PMID 17454625·Leuk Lymphoma·2007
3-trial
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
PMID 17213020·Cancer Genet Cytogenet·2007
8-other
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.
PMID 16524969·Ann Oncol·2006
8-other
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
PMID 15920548·Mod Pathol·2005
8-other
Hematopoietic stem cell transplantation in mantle cell lymphoma.
PMID 15781489·Ann Oncol·2005
4-observational
Follicular lymphoma: expanding therapeutic options.
PMID 15770890·Oncology (Williston Park)·2005
6-review
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
PMID 14660050·Cytotherapy·2003
3-trial
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.
PMID 14501873·Transplantation·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 988102 NEBRASKA MEDICAL CTR
OMAHA, NE 68198 - Phone
- (402) 559-9800
Quick Facts
- NPI
- 1942268768
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile